Market Research Logo

Asia Pacific Blood Plasma Market Forecast 2018-2026

Asia Pacific Blood Plasma Market Forecast 2018-2026

KEY FINDINGS

The Asia-Pacific region is expected to rise with the fastest CAGR of 6.87% for the forecast period of 2018-2026. The market’s enhanced potential for growth in the past few years has encouraged several companies to invest in this region.

MARKET INSIGHTS

The Indian market is likely to witness a significant growth in this region due to increasing hemophilic population and growing efforts to manufacture blood plasma derivatives in the region, instead of outsourcing them. The Japan market presently accounts for a major market share of the Apac. This is followed by China and Australia. However, a low number of established regional market players and low awareness regarding blood plasma therapies are restraining the overall APAC blood plasma market’s growth.

COMPETITIVE INSIGHTS

Companies like Arthrex, China Biologic Products Inc, Adma Biologics Inc, General Electric Co, Shire Plc, Grifols International S.A, Cerus Corp, Biotest Ag, Octopharma Ag and Baxter International Inc are engaged in this market.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Provision Of Better Healthcare Infrastructure In Developed Countries
3.2.2. Immunoglobulin Blood Type To Hold The Largest Market Share By 2026
3.2.3. Transplantation Is Anticipated To Be The Fastest Growing Application In Blood Plasma
4. Market Determinants
4.1. Market Drivers
4.1.1. Exploitation Of New Therapeutic Indications
4.1.2. Rising Prevalence Of Alpha-1 Antitrypsin Deficiency (Aatd)
4.1.3. Increase In Patient Pool For Hemophilia Treatment
4.2. Restraints
4.2.1. Swelling Use Of Recombinant Plasma Products In Therapeutic Treatments
4.2.2. High Costs Of Blood Plasma Treatments
4.2.3. Adverse Reactions Associated With Post-transfusion
4.3. Opportunities
4.3.1. Rising Incidence Of Hemophilia
4.3.2. Growing Public Awareness
4.3.3. New Product Opportunities
4.4. Challenges
4.4.1. Spread Of Pathogenic Contaminants
4.4.2. High Regulations In The Market
5. Market By Mode Of Delivery
5.1. Infusion Solutions
5.2. Gels
5.3. Sprays
5.4. Biomedical Sealants
6. Market Segmentation
6.1. Market By Blood Type 2018-2026
6.1.1. Immunoglobulin
6.1.1.1. Intravenous Immunoglobulin
6.1.1.2. Subcutaneous Immunoglobulin
6.1.1.3. Other Immunoglobulin Type
6.1.2. Albumin
6.1.3. Hyperimmunes
6.1.4. Coagulation Factor Concentrates
6.1.5. Other Plasma Fractionation Products
6.2. Market By Application 2018-2026
6.2.1. Immunology
6.2.2. Oncology
6.2.3. Pulmonology
6.2.4. Rheumatology
6.2.5. Transplantation
6.2.6. Neurology
6.2.7. Haematology
6.2.8. Other Applications
6.3. Market By End User 2018-2026
6.3.1. Hospitals And Clinics
6.3.2. Research Laboratories
6.3.3. Academic Institutions
7. Key Analytics
7.1. Porter’s Five Forces Analysis
7.1.1. Threat Of New Entrants
7.1.2. Threat Of Substitutes
7.1.3. Bargaining Power Of Buyers
7.1.4. Bargaining Power Of Suppliers
7.1.5. Threat Of Rivalry
7.2. Plasma Therapeutics Regulation
7.3. Market Trends
7.4. Regulatory Agencies
7.5. Clinical Guidelines
8. Geographical Analysis
8.1. Asia-pacific
8.1.1. Japan
8.1.2. China
8.1.3. Australia
8.1.4. India
8.1.5. Rest Of Asia-pacific
9. Company Profiles
9.1. Adma Biologics Inc.
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.3. Strategic Initiatives
9.2. Arthrex
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Scot Analysis
9.2.4. Strategic Moves
9.3. Baxter International Inc.
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Scot Analysis
9.4. Biotest Ag
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Strategic Initiatives
9.5. Cerus Corp.
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Strategic Initiatives
9.6. China Biologic Products Inc.
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Strategic Initiatives
9.7. Csl Ltd.
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Product Portfolio
9.8. General Electric Co.
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Swot Analysis
9.8.4. Strategic Initiatives
9.9. Grifols International S.A.
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Strategic Initiatives
9.10. Octopharma Ag
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Strategic Initiatives
9.11. Shire Plc
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Scot Analysis
9.11.4. Strategic Initiatives
Table List
Table 1 Asia Pacific Blood Plasma Market 2018-2026 ($ Million)
Table 2 Blood Plasma Components
Table 3 Asia Pacific Blood Plasma Market By Blood Type 2018-2026 ($ Million)
Table 4 Asia Pacific Blood Plasma Market In Immunoglobulin 2018-2026 ($ Million)
Table 5 Asia Pacific Blood Plasma Market In Immunoglobulin By Types 2018-2026 ($ Million)
Table 6 Asia Pacific Immunoglobulin Market In Intravenous Immunoglobulin 2018-2026 ($ Million)
Table 7 Asia Pacific Immunoglobulin Market In Subcutaneous Immunoglobulin 2018-2026 ($ Million)
Table 8 Asia Pacific Immunoglobulin Market In Other Immunoglobulin Type 2018-2026 ($ Million)
Table 9 Asia Pacific Blood Plasma Market In Albumin 2018-2026 ($ Million)
Table 10 Asia Pacific Blood Plasma Market In Hyperimmunes 2018-2026 ($ Million)
Table 11 Asia Pacific Blood Plasma Market In Coagulation Factor Concentrates 2018-2026 ($ Million)
Table 12 Asia Pacific Blood Plasma Market In Other Plasma Fractionation Products 2018-2026 ($ Million)
Table 13 Protease Inhibitors Used In The Hiv Infection Treatment
Table 14 Asia Pacific Blood Plasma Market By Application 2018-2026 ($ Million)
Table 15 Asia Pacific Blood Plasma Market In Immunology 2018-2026 ($ Million)
Table 16 Asia Pacific Blood Plasma Market In Oncology 2018-2026 ($ Million)
Table 17 Asia Pacific Blood Plasma Market In Pulmonology 2018-2026 ($ Million)
Table 18 Asia Pacific Blood Plasma Market In Rheumatology 2018-2026 ($ Million)
Table 19 Asia Pacific Blood Plasma Market In Transplantation 2018-2026 ($ Million)
Table 20 Asia Pacific Blood Plasma Market In Neurology 2018-2026 ($ Million)
Table 21 Asia Pacific Blood Plasma Market In Hematology 2018-2026 ($ Million)
Table 22 Asia Pacific Blood Plasma Market In Other Applications 2018-2026 ($ Million)
Table 23 Asia Pacific Blood Plasma Market By End User 2018-2026 ($ Million)
Table 24 Asia Pacific Blood Plasma Market In Hospitals And Clinics 2018-2026 ($ Million)
Table 25 Asia Pacific Blood Plasma Market In Research Laboratories 2018-2026 ($ Million)
Table 26 Asia Pacific Blood Plasma Market In Academic Institutions 2018-2026 ($ Million)
Table 27 Asia Pacific Blood Plasma Market 2018-2026 ($ Million)
Figures List
Figure 1 Asia Pacific Blood Plasma Market 2018-2026 ($ Million)
Figure 2 Immunoglobulin Infusions Side Effects
Figure 3 Role Of Fibrin Sealant In Coagulation Cascade
Figure 4 Asia Pacific Blood Plasma Market In Immunoglobulin 2018-2026 ($ Million)
Figure 5 Asia Pacific Blood Plasma Market In Albumin 2018-2026 ($ Million)
Figure 6 Hyperimmunes Isolation Process
Figure 7 Asia Pacific Blood Plasma Market In Hyperimmunes 2018-2026 ($ Million)
Figure 8 Asia Pacific Blood Plasma Market In Coagulation Factor Concentrates 2018-2026 ($ Million)
Figure 9 Asia Pacific Blood Plasma Market In Other Plasma Fractionation Products 2018-2026 ($ Million)
Figure 10 Asia Pacific Blood Plasma Market In Immunology 2018-2026 ($ Million)
Figure 11 Asia Pacific Blood Plasma Market In Oncology 2018-2026 ($ Million)
Figure 12 Asia Pacific Blood Plasma Market In Pulmonology 2018-2026 ($ Million)
Figure 13 Lupus Infection Symptoms
Figure 14 Asia Pacific Blood Plasma Market In Rheumatology 2018-2026 ($ Million)
Figure 15 Asia Pacific Blood Plasma Market In Transplantation 2018-2026 ($ Million)
Figure 16 Asia Pacific Blood Plasma Market In Neurology 2018-2026 ($ Million)
Figure 17 Asia Pacific Blood Plasma Market In Hematology 2018-2026 ($ Million)
Figure 18 Asia Pacific Blood Plasma Market In Other Applications 2018-2026 ($ Million)
Figure 19 Asia Pacific Blood Plasma Market In Hospitals And Clinics 2018-2026 ($ Million)
Figure 20 Asia Pacific Blood Plasma Market In Research Laboratories 2018-2026 ($ Million)
Figure 21 Asia Pacific Blood Plasma Market In Academic Institutions 2018-2026 ($ Million)
Figure 22 Japan Blood Plasma Market 2018-2026 ($ Million)
Figure 23 China Blood Plasma Market 2018-2026 ($ Million)
Figure 24 Australia Blood Plasma Market 2018-2026 ($ Million)
Figure 25 India Blood Plasma Market 2018-2026 ($ Million)
Figure 26 Rest Of Asia-pacific Blood Plasma Market 2018-2026 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report